Vancouver, October 19, 2026 - TheNewswire – Mr. Jerzy Wilczewski announces the disposition of 800,000 common shares (“Common Shares”) in the capital of Helix Biopharma Corp. (“Helix” or the “Corporation”) (TSX: HBP) at a price of C$1.30 per Common Share by way of sale carried out privately, for an aggregate amount of C$1,040,000 (the “Transaction”).

This press release is being disseminated pursuant to National Instrument 62-103 The Early Warning System and Related Take-Over Bid and Insider Reporting Issues ("National Instrument 62-103").

As a result of the Transaction, Mr. Wilczewski beneficially owns, or exercises control or direction over, 7,548,986 Common Shares of the Corporation, representing approximately 9.88% of the issued and outstanding Common Shares on non-diluted and partially diluted basis. Immediately prior to the closing of the Transaction, Mr. Wilczewski beneficially owned, or exercised control or direction over, 8,348,986 Common Shares, representing approximately 10.93% of the issued and outstanding Common Shares on non-diluted and partially diluted basis. Mr. Wilczewski also holds 1,260 convertible debentures of the Corporation, which are due to mature on August 2, 2027. As the convertible debentures do not provide for conversion at the holder’s option prior to maturity, they have been excluded from the calculation of Mr. Wilczewski partially diluted ownership as of the date of this press release. Mr. Wilczewski’s ownership position will be reassessed upon maturity of the convertible debentures.

The Common Shares described herein were disposed of for investment purposes. Mr. Wilczewski may increase or decrease his ownership, directly or indirectly, of securities of the Company from time to time in open market or private acquisitions or dispositions depending on market conditions and/or other relevant factors.

A copy of the early warning report to be filed by Mr. Wilczewski in connection with the Transaction described herein will be available on SEDAR+ under the Corporation’s profile at www.sedarplus.ca.

For further information or a copy of Mr. Wilczewski's early warning report, please contact

Mr. Jerzy Wilczewski

+48 50 228 1989

Copyright (c) 2026 TheNewswire - All rights reserved.